Full Breakdown
Tandem Health Secures $100 Million Series B Led by Scaleup Europe Fund
By Drooid · · How we work
Background & Context
European health systems face a projected shortfall of 1.6 million health and social-care workers in 2024, rising to 4 million by 2030 (WHO). Tandem Health, founded in 2023 in Stockholm, offers an AI-driven clinical platform to address these pressures.
The Scaleup Europe Fund, a €5 billion vehicle managed by EQT, targets deep-tech, AI, and life-science companies from Series B to pre-IPO stages. The September 14 2026 investment is its first commitment to a healthcare AI firm.
Product Overview & Certifications
Tandem’s AI Medical Assistant combines AI Scribe, Coding Assistant, and Clinical Decision Support, each certified as a Class IIa medical device under the EU MDR. Additional certifications include ISO 27001, ISO 13485, ISO 42001, C5 (Germany), ENS High (Spain) and HDS (France). The platform integrates with more than 130 EMR systems and is deployed in over 10 000 care organisations across 14 European markets.
Data & Statistics
- Funding: $100 million Series B (Sept 14 2026) led by the Scaleup Europe Fund; $50 million Series A closed in 2025; total capital raised $160 million.
- Market reach: >10 000 care organisations; presence in 14 European markets; integration with >130 EMR systems.
- Clinician outcomes (peer-reviewed study, *JMIR Medical Informatics*, July 10 2026):
- Documentation time per note fell from 6.69 min to 4.72 min (-29 %).
- Survey respondents reported a 30 % improvement in job satisfaction and a 30 % reduction in administrative stress.
- 80.2 % said the scribe improved their profession; 91.0 % found it easy to use; 91.5 % wished to continue using it; 84.2 % would recommend it.
- Cohort: 1 295 clinicians (66.5 % GPs), 236 153 notes, data collected Apr 26 2024–Oct 27 2025.
Official Statements & Responses
Lukas Saari, CEO and co-founder, said “Europe should be setting the standard for how AI enters healthcare,” adding that the new capital will fund the transition to an AI-native Clinic Operating System handling triage, scheduling and patient communication.
Why It Matters
By cutting administrative time by roughly one-third, Tandem’s platform directly addresses the workforce gap, freeing clinicians for patient care. Its EU-centric certifications and data-sovereignty architecture align with European regulatory expectations, reducing reliance on foreign AI solutions.
Timeline
- 2023: Tandem Health founded in Stockholm.
- 2025: $50 million Series A closed.
- July 10 2026: Peer-reviewed study on the AI Scribe published.
- September 14 2026: $100 million Series B announced.
